MaxwellM

Really spectacular analysis – thank you for sharing, fun to scroll and easy to understand.

Is it possible to expand this analysis beyond words to other Claude ticks? Contrastive framings, sentence length, caveating, for instance.

my "belt and suspenders" are "load-bearing"

Very exciting!

Agreed. Logseq changed the game for me. Because SRS is closely coupled with note-taking and is as simple as adding "#card", it eliminates any friction and excuses I had for not using SRS. I look forward to adding new cards as much as I do reviewing old ones.

Thanks for sharing. This was a compelling argument that nudged my understanding in a new direction.

I recently started paying creators on Patreon and subscribing to news outlets I wanted to support. But within a year, I realized that this was inefficient, I didn't like/read/watch most of the content that my subscriptions were supporting. As much as I wanted to support the content creators and quality journalism, I questioned the value of my subscriptions and cancelled - I felt like I signed up for a gym membership on Jan 1st that I wasn't using anymore.

Ads allow me "to pay" with my attention for only the content that I value. I don't like ads, I generally use an ad-blocker, but I appreciate the post and the perspective.

Using Google Reader felt like hanging out and having a beer with my favorite friends. It was teeming with conversation threads waiting to be pulled.

Seeing a new share was like getting a tiny intellectual present, filled with all the right connotations - "Here's this thing I think you would find interesting," "I care about your opinion, what are your thoughts on this," "It's not important, but it is entertaining," "not trying to share this with the world, just you, my friend."

Google Reader was our company's post-lunch ritual. A way to balance a mornings worth of engineering effort and soporific pad thai with a jolt of fresh news and virtual office banter.

RIP.

Congratulations, this is exciting. Canned solutions are a good way to get young companies from zero to one quickly

Amazing work here. The slow build, the clear code with highlighting, and the suggested improvements at the end - all made this easy to read and follow along!

Also maybe, try to innovate instead of suffocating innovation with a pillow stuffed with cash.

As a data scientist excited about the potential of psychedelic therapies, I like that you are helping bring rigor to the space. I imagine supplementing clinical data with feedback from daily in-app experience sampling could help validate or invalidate new therapies. Keen to follow along and possibly get involved in the future.